Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHARMACOLOGY (2nd year) > DR. LEAL - AUTONOMIC DRUGS PART2 > Flashcards

DR. LEAL - AUTONOMIC DRUGS PART2 Flashcards

1
Q

activates receptor for adrenaline or epinephrine or norepinephrine

A

ADRENOCEPTOR AGONIST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mimics the sympathetic nervous system

A

SYMPATHOMIMETIC DRUGS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

− Directly interact with and activate adrenoceptors.
− eg, NOREPINEPHRINE and EPINEPHRINE

A

DIRECT AGONISTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

− Actions are dependent on their ability to enhance the actions of endogenous (naturally occurring in the body) catecholamines (norepinephrine, epinephrine, dopamine)

A

INDIRECT AGONISTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Inducing the release of catecholamines by displacing them from adrenergic nerve endings (mechanism of action of ______)

A

TYRAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

not physiologically important in humans but if under the treatment of monoamine oxidase inhibitors, THIS can accumulate. If medicating with MAO inhibitors, avoid cheese or protein-rich foods.

A

TYRAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Decreasing the clearance of catecholamines by inhibiting their neuronal reuptake (mechanism of action of ____ & _____)

A

COCAINE
TCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Receptors for acetylcholine

A

NICOTINIC
MUSCARINIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacologic effects of INDIRECT SYMPATHOMIMETICS are greater under conditions of:

A

a. Increased sympathetic activity.
b. Norepinephrine storage and release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Receptors for noradrenergic

A

ALPHA
BETA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

sublingually administered for emergency treatment of hypertensive urgency. If BP is 180/100, it is used to acutely decrease the BP of the patient.

A

CLONIDINE (CATAPRES)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

used if BP is decreased

A

PHENYLEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

has atropine, it can increase the heart rate so avoid giving it to patients with arrhythmia.

A

LOMOTIL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

greater affinity in α1 > α2

A

PHENYLEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

greater affinity in α2 > α1

A

CLONIDINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

have the same affinity to both α1 and α2

A

NE
EPINEP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

mostly found in blood vessels = contraction = increase BP

A

α1 (ALPHA1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

NE or Epi (will attach to β1 in the heart) is used in CPR to increase the force or contraction of the heart

A

β1 (BETA 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

given to asthmatic patients to relieve bronchial smooth muscles but still has a side effect to increase the heart rate of patients.

A

ISOPROTERENOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Used in CPR to increase contractility of the heart, and increase heart rate, stroke volume, cardiac output, and blood pressure of the patient.

A

EPINEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

GIVEN to patients with decreased blood pressure and increased heart rate to increase BP without increasing the heart rate.

A

PHENYLEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

• Agonist at both α and β receptors
• Very potent vasoconstrictor and cardiac stimulant

A

EPINEPHRINE (ADRENALINE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The rise in systolic blood pressure that occurs after
epinephrine release or administration is caused by its

A

positive inotropic and chronotropic actions on the heart (predominantly β 1receptors) and the vasoconstriction induced in many vascular beds (α receptors).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

epinephrine functions largely as a _____; it is released from the adrenal medulla and carried in the blood to distant sites of action.

A

HORMONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

• Agonist at both α1 and α2 receptors
• Also activates β1 receptors with similar potency as
epinephrine, but has relatively little effect on β2 receptors.
• Increases peripheral resistance and both diastolic and
systolic blood pressure.

A

NOREPINEPHRINE (LEVARTERENOL, NORADRENALINE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

• Immediate precursor in the synthesis of norepinephrine.

A

DOPAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Rate-limiting step in the formation of NE

A

CONVERSION OF TYROSINE TO DOPAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Endogenous dopamine may have more important effects in

A

regulating sodium excretion and renal function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Deficiency in the basal ganglia leads to Parkinson’s disease, which is treated with its precursor Levodopa.

A

DOPAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

• A prodrug that is enzymatically hydrolyzed to desglymidodrine, a selective α1-receptor agonist (peak concentration of desglymidodrine is achieved about 1 hour after midodrine is administered orally)

A

MIDODRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Treatment of orthostatic hypotension, typically due to impaired autonomic nervous system function.

• Increases upright blood pressure and improves orthostatic tolerance, but it may cause hypertension when the subject is supine

A

MIDODRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Decrease blood pressure through actions in the CNS that
reduce sympathetic tone (“sympatholytics”) even though direct application to a blood vessel may cause
vasoconstriction.

A

ALPHA 2-SELECTIVE AGONISTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

are useful in the treatment of hypertension.
SE (side effects): Sedation

A

CLONIDINE
METHYLDOPA (for pregnant with high BP)
GUANFACINE
GUANABENZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

for sedation in an intensive care setting or before anesthesia. Can be given to patients who will undergo MRI or CT scan.

A

DEXMEDETOMIDINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

used as a centrally-acting muscle relaxant.

A

TIZANIDINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

• Topical decongestant - ability to promote constriction of
the vessels in the nasal mucosa and conjunctiva.
• Large doses may cause hypotension, presumably because of a central clonidine-like effect. Should not be given to
already hypotensive patients.

A

OXYMETAZOLINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q
  • Has positive chronotropic and inotropic actions.
  • Because IT activates β receptors almost
    exclusively, it is a potent vasodilator.
A

ISOPROTERENOL (ISOPRENALINE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

• Positive inotropic action caused by the isomer with
predominantly β-receptor activity

A

DOBUTAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

• Component of many decongestant mixtures.
• Precursor in the illicit manufacture of methamphetamine. • Given to ongoing operation to increase BP especially if
becoming hypotensive due to blood loss.

A

EPHEDRINE & PSEUDOEPHEDRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

TRUTH SERUM

A

KETAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

• Racemic mixture of phenylisopropylamine.
• Use and misuse as a CNS stimulant.

A

AMPHETAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

• Pharmacokinetically similar to EPHEDRINE; however, enters the CNS even more readily, where it has marked stimulant effects on mood and alertness and a depressant effect on appetite

• Actions are mediated through the release of NOREPINEPHRINE and, to some extent, dopamine.

A

AMPHETAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

• Very similar to amphetamine, with an even higher ratio of central to peripheral actions.

A

METHAMPHETAMINE (N-methylamphetamine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

• An amphetamine variant
• Major pharmacologic effects and abuse potential are
similar to those of amphetamine

A

METHYLPHENIDATE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

used to increase BP.

A

Methamphetamine
Methylphenidate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Shabu users: decreased sleep, hyperactive and some had heart failures because of increased heart rate and BP.

A

METHYLPHENIDATE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

• A psychostimulant that differs from amphetamine in
structure, neurochemical profile, and behavioral effects

A

MODAFINIL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

• Primarily to improve wakefulness in narcolepsy and some other conditions

A

MODAFINIL

49
Q

• Anormal byproduct of tyrosine metabolism in the body
• An indirect sympathomimetic, inducing the release of
catecholamines from noradrenergic neurons

A

TYRAMINE

50
Q

In patients treated with MAO inhibitors—particularly inhibitors of the MAO-A isoform—the sympathomimetic effect of tyramine may be greatly intensified, leading to marked increases in blood pressure. This occurs because of increased bioavailability of tyramine and increased neuronal stores of catecholamines.

A

TYRAMINE

51
Q

Patients taking MAO inhibitors should avoid tyramine-
containing foods

A

aged cheese
cured meats
pickled food

52
Q

• A selective inhibitor of the norepinephrine uptake
• Actions are mediated by the potentiation of
norepinephrine levels in noradrenergic synapses
• Used in the treatment of ATTENTION DEFICIT DISORDERS.

A

ATOMOXETINE

53
Q

• Has similar characteristics to Atomoxetine but is used mainly for MAJOR DEPRESSION DISORDER.

• Reuptake inhibitors potentiate norepinephrine actions (cardiovascular safety)

A

REBOXETINE

54
Q

• Serotonin and norepinephrine reuptake inhibitors used as an appetite suppressant.

A

SIBUTRAMINE

55
Q

• Widely used antidepressant with balanced serotonin and norepinephrine reuptake inhibitory effects
• Treatment of pain in fibromyalgia.

A

DULOXETINE

56
Q

• A local anesthetic with a peripheral sympathomimetic
action that results from the inhibition of transmitter
reuptake at noradrenergic synapses.

A

COCAINE

57
Q

• Readily enters the CNS and produces an amphetamine-
like psychological effect that is shorter lasting and more
intense than amphetamine

A

COCAINE

58
Q
  • Major action of ____ in the CNS is to inhibit dopamine
    reuptake into neurons in the “pleasure centers” of the brain.
A

COCAINE

59
Q
  • Converted to dopamine in the body
  • Dopamine agonists
  • Treatment of Parkinson’s disease and prolactinemia.
A

LEVODOPA

60
Q

D1-receptor agonist that selectively leads to peripheral vasodilation in some vascular beds
• IV treatment of severe hypertension.

A

FENOLDOPAM

61
Q

may be required in cases of sustained hypotension with evidence of tissue hypoperfusion.

A

Sympathomimetics

Treatment of Acute Hypotension

62
Q

• A complex acute cardiovascular syndrome that results in a critical reduction in perfusion of vital tissues and a wide range of systemic effects

A

SHOCK

63
Q

The mainstay of treatment especially in hypovolemic shock

A

replacement of volume example severe diarrhea / bleeding = hypovolemic shoc
k

64
Q

vasopressor of first choice to increase BP

A

NOREPINEPHRINE

65
Q

• •
Impairment of autonomic reflexes that regulate blood pressure
Increasing peripheral resistance is one of the strategies to treat chronic orthostatic
hypotension (drugs activating α receptors can be used for this purpose)

A

Chronic Orthostatic Hypotension

66
Q

o A prodrug that is converted to norepinephrine by
the aromatic L-amino acid decarboxylase (dopa- decarboxylase), the enzyme that converts L-dopa to dopamine.

A

DROXIDOPA

67
Q

o Improves the chance of returning to spontaneous circulation.

A

CARDIAC APPLICATIONS
EPINEPHRINE

68
Q

o Used as a pharmacologic cardiac stress test
o Augments myocardial contractility and promotes
coronary and systemic vasodilation.

A

DOBUTAMINE

69
Q

used in the nares for vasoconstriction to avoid excessive bleeding

A

Oxymetazoline

70
Q

o Effective mydriatic agent frequently used to facilitate examination of the retina
o Decongestant for minor allergic hyperemia and itching of the conjunctival membranes.

A

PHENYLEPHRINE

71
Q

dissociate from receptors, and the block can be surmounted with sufficiently high concentrations of agonists

• Phentolamine and Prazosin
• Labetalol
• Several Ergot derivatives

A

REVERSIBLE ANTAGONISTS

72
Q

• Management of hypertension
• Highly selective for α1 receptors and typically 1000-fold
less potent at α2 receptors

A

PRAZOSIN

73
Q

• Reversible α1-selective antagonist that is effective in
hypertension.
• Men with urinary retention symptoms due to BENIGN
PROSTATIC HYPERPLASIA (BPH)

A

TERAZOSIN

74
Q

• Treatment of Hypertension and BPH

A

DOXAZOSIN

75
Q

• Binds covalently to α receptors, causing irreversible
blockade of long duration (14–48 hours or longer)
• Somewhat selective for α1 receptors but less so than
Prazosin

A

PHENOXYBENZAMINE

76
Q

• Most significant effect is attenuation of catecholamine-
induced vasoconstriction.
• It reduces blood pressure when sympathetic tone is high,
eg, as a result of upright posture or because of reduced
blood volume

A

PHENOXYBENZAMINE

77
Q

Adverse Effects:
a. Orthostatic Hypotension and Tachycardia
b. Nasal stuffiness and inhibition of ejaculation
c. Enters the CNS (may cause fatigue, sedation and
nausea

A

PHENOXYBENZAMINE

78
Q

Treatment of PHEOCHROMOCYTOMA.

A

PHENTOLAMINE

79
Q

Treatment of ORTHOSTATIC HYPOTENSION

Treat MALE ERECTILE DYSFUNCTION

A

YOHIMBINE

80
Q

• Greater potency in inhibiting contraction in PROSTATE
smooth muscle versus vascular smooth muscle compared
with other α1-selective antagonists
• Drug’s efficacy in BPH (benign prostatic hyperplasia)

A

TAMSULOSIN

81
Q

• α1-selective quinazoline derivative that is approved for
use in BPH

A

ALFUZOSIN

82
Q

• Resembles Tamsulosin in blocking the α1A receptor and is
also used in the treatment of BPH.

A

SILODOSIN

83
Q

• α1- selective antagonist that also has efficacy as an
antihypertensive.

A

INDORAMIN

84
Q

• α1 antagonist (its primary effect) that also has weak α2-
agonist and 5-HT1A-agonist actions and weak antagonist
action at β1 receptors
• Antihypertensive agent and for BPH.

A

URAPIDIL

85
Q

Have both α1-selective and β-antagonistic effects
Somewhat selective for β1 and β2 receptors than α receptors.

A

(MIXED ANTAGONISTS)
LABETALOL and CARVEDILOL

86
Q

PHARMACODYNAMICS OF THE BETA-RECEPTOR ANTAGONIST DRUGS

EFFECTS ON THE CARDIOVASCULAR SYSTEM

A

• Lower blood pressure in patients with hypertension
• Suppression of renin release and effects in the CNS
• Treatment of angina, chronic heart failure and following
myocardial infarction

87
Q

PHARMACODYNAMICS OF THE BETA-RECEPTOR ANTAGONIST DRUGS

EFFECTS ON THE RESPIRATORY TRACT

A

INCREASE IN AIRWAY RESISTANCE

88
Q

PHARMACODYNAMICS OF THE BETA-RECEPTOR ANTAGONIST DRUGS
EFFECTS ON EYE

A

• Reduce intraocular pressure, especially in GLAUCOMA.
• Mechanism: DECREASED AQUEOUS HUMOR
PRODUCTION

89
Q

inhibits sympathetic nervous system
stimulation of lipolysis.

A

PROPANOLOL

90
Q

much safer in those TYPE 2
DIABETIC patients who do not have hypoglycemic
episodes.

A

Beta-receptor antagonists

91
Q

• Has negligible effects at α and muscarinic receptors;
however, it may block some serotonin receptors in the brain.

A

PROPANOLOL

92
Q

• SAFER in patients who experience bronchoconstriction in
response to propranolol
• Preferable in patients with DIABETES or PERIPHERAL
VASCULAR DISEASE when therapy with a β blocker is required.

A

METOPROLOL & ATENOLOL

93
Q

• Most highly selective β1-adrenergic receptor blocker.
- ADDITIONAL QUALITY OF VASODILATION
- MAY INCREASE INSULIN SENSITIVITY

A

NEBIVOLOL

94
Q

• Non selective agent with no local anesthetic activity
• Has excellent ocular hypotensive effects when
administered topically in the eye.

A

TIMOLOL

95
Q

• Very long duration of action
• Spectrum of action is similar to that of TIMOLOL.

A

NADOLOL

96
Q

Used for topical ophthalmic application in GLAUCOMA.

A

LEVOBUNOLOL
BETAXOLOL

97
Q

• Effective in the major cardiovascular applications of the β-
blocking group (HYPERTENSION AND ANGINA)

A

PINDOLOL, ACEBUTOLOL, CARTEOLOL, BOPINDOLOL, OXPRENOLOL, CELIPROLOL, AND PENBUTOLOL

98
Q

• Hypotension induced is accompanied by LESS TACHYCARDIA than occurs with phentolamine and similar α blockers.

A

LABETALOL

99
Q

• Ultra-short-acting β1-selective adrenoceptor antagonist

• Useful in controlling SUPRAVENTRICULAR ARRHYTHMIAS, ARRHYTHMIAS associated with thyrotoxicosis, perioperative hypertension, and myocardial ischemia in acutely ill patients

A

ESMOLOL

100
Q
  1. An effective mydriatic and decongestant that can be used to raise the blood pressure, an effective ophthalmic drug
    a. Amphetamine
    b. Phenylephrine
    c. Tizanidine
    d. Midodrine
A

B

101
Q
  1. Treatment for Parkinson’s disease and Prolactinemia
    a. Fenoldopam
    b. Tyramine
    c. Levodopa
    d. BothAandC
A

C

102
Q
  1. Treatment of pheochromocytoma, it is used to reverse local anesthesia in soft tissue sites
    a. Yohimbine
    b. Talozoline
    c. Phentolamine
    d. Phenoxybenzamine
A

C

103
Q
  1. Major action in the CNS is to inhibit dopamine reuptake into neurons in the ‘pleasure centers’ of the brain.
    a. Atomoxetine
    b. Cocaine
    c. Fenoldopam
    d. Sibutramine
A

B

104
Q
  1. Used for topical ophthalmic application in glaucoma
    a. Levobunolol
    b. Bopindolol
    c. Betaxolol
    d. BothAandC
A

D

105
Q
  1. A prodrug that is used for treatment of orthostatic hypotension, it increases upright blood pressure and improves orthostatic tolerance, but may cause hypertension when the subject is supine
    a. Phenmetrazine
    b. Phenylephrine
    c. Tizanidine
    d. Midodrine
A

D

106
Q
  1. Most common on effector cell membranes, especially glandular and smooth muscle cells
    a. M1 receptor
    b. M2 receptor
    c. M3 receptor
    d. M4 receptor and M5 receptor
A

C

107
Q
  1. Less prominent and appear to play a greater role in the CNS than in the periphery
    a. M1 receptor
    b. M2 receptor
    c. M3 receptor
    d. M4 receptor and M5 receptor
A

D

108
Q
  1. Inhibits both norepinephrine and dopamine transporters, improves wakefulness in narcolepsy.
    A. Modafinil
    B. Tyramine
    C. Methylphenidate
    D. Methamphetamine
A

A

109
Q
  1. In noradrenergic nerve ending by a sodium-dependent carrier and then converted to dopamine.
    adrenergic transmission, _____ is transported into the
    a. Choline
    b. Tyrosine
    c. Norepinephrine
    d. Leucine
A

B

110
Q
  1. Which of the following agents produces a vasopressor effect that can relieve nasal congestion?
    a. Atropine
    b. Reserpine
    c. Cocaine
    d. Mecamylamine
A

C

111
Q
  1. What is the predominant adrenoceptor in heart muscle?
    A. α1-adrenoceptor
    B. α2-adrenoceptor
    C. β1-adrenoceptor
    D. β2-adrenoceptor
A

C.

112
Q
  1. THE prototype of beta-receptor antagonist drugs
    A. Atenolol
    B. Propranolol
    C. Timolol
    D. Metoprolol
A

B

113
Q
  1. THE following has local anesthetic action except:
    A. Labetalol
    B. Esmolol
    C. Metoprolol
    D. Propranolol
A

B

114
Q
  1. This drug may elicit extrapyramidal effects.
    a. Carvedilol
    b. Butoxamine
    c. Metyrosine
    d. Esmolol
A

C

115
Q
  1. Antimuscarinic drug used in ophthalmology with the shortest duration of effect
    a. Atropine
    b. Tropicamide
    c. Scopolamine
    d. Cyclopentolate
A

B

116
Q
  1. What is the main clinical use for agonists of the β2- adrenoceptor?
    A. Treatment of hypertension
    B. Treatment of angina
    C. Treatment of asthma
    D. Treatment of pain
    E. All of the above
A

C

117
Q
  1. Ultra-short–acting β1-selective adrenoceptor antagonist that is rapidly metabolized by esterases in red blood cells.
    a. Esmolol
    b. Metoprolol
    c. Labetalol
    d. Carvedilol
A

A

118
Q
  1. What part of a neuron is responsible for receiving information?
    A. Axon
    B. Terminal fiber
    C. Dendrite
    D. Myelin sheath
    E. Nucleus
A

C

119
Q
  1. Preparing the body for “flight-or-fight” response during threatening situations is the role of the?
    a. Autonomicnervoussystem
    b. Somatic nervous system
    c. Parasympathetic nervous system
    d. Sympathetic nervous system
    e. cerebrum
A

D.

PHARMACOLOGY (2nd year) (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions